News & Events
Congratulations to NanoRay Biotech for its anticancer therapy approved by the US FDA for Clinical Trial
Congratulations to NanoRay Biotech Co., Ltd.’s [Auger Molecular Therapy], which has been approved by the US FDA for Clinical Trial.
September 29, 2022
BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs
(Shanghai August 8, 2022) – BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International
August 08, 2022
Bioduro-Sundia’s Wuxi GMP Manufacturing Facility Granted the Drug Manufacturing License
(Shanghai,Jul 1st, 2022) –BioDuro-Sundia, a leading drug discovery, development and commercial services organization backed by Advent International
July 01, 2022
BioDuro-Sundia Appoints Kent Payne CEO
(San Diego,Feb 14, 2022) –BioDuro-Sundia, a leading drug discovery, development and commercial services organization backed by Advent International, announced today the appointment of Kent M. Payne, PhD, as Chief Executive Officer. He originally joined BioDuro-Sundia in 2019 as President, Global CMC Solutions.
February 14, 2022
Congratulations to Dr. Junbo Wang & his team for winning the Best Collaboration Award of Luye Pharma in 2021
(Shanghai, January 20, 2022)— Dr. Junbo Wang & his team from BioDuro-Sundia’s Chemistry department won the ” Best Collaboration Award ” issued by Luye Pharma, in recognition of their great contribution for drug chemistry discovery projects in 2021.
January 20, 2022
Total 68 12345678...1314
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all